Header cover image

Banks Healthcare Sector

Results

2311

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,311 companies

CareDx

Market Cap: US$892.0m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

CDNA

US$16.10

7D

4.6%

1Y

8.9%

Nutex Health

Market Cap: US$877.9m

Operates as a physician-led, healthcare services, and operations company in the United States.

NUTX

US$173.76

7D

44.0%

1Y

2,258.6%

Pharvaris

Market Cap: US$875.7m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

PHVS

US$15.91

7D

-6.6%

1Y

-26.7%

STAAR Surgical

Market Cap: US$863.0m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

STAA

US$18.29

7D

-6.3%

1Y

-57.1%

Extendicare

Market Cap: CA$1.2b

Through its subsidiaries, provides care and services for seniors in Canada.

EXE

CA$14.52

7D

2.3%

1Y

99.5%

AMN Healthcare Services

Market Cap: US$833.5m

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

AMN

US$22.38

7D

10.1%

1Y

-62.1%

HealthStream

Market Cap: US$826.6m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

HSTM

US$27.57

7D

1.2%

1Y

0.9%

Avadel Pharmaceuticals

Market Cap: US$825.2m

Operates as a biopharmaceutical company in the United States.

AVDL

US$8.89

7D

-5.3%

1Y

-44.2%

Intellia Therapeutics

Market Cap: US$816.2m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

NTLA

US$8.08

7D

-2.5%

1Y

-69.1%

SI-BONE

Market Cap: US$799.0m

A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

SIBN

US$18.88

7D

3.0%

1Y

24.8%

Syndax Pharmaceuticals

Market Cap: US$798.5m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

SNDX

US$8.95

7D

-18.7%

1Y

-57.2%

Niagen Bioscience

Market Cap: US$797.3m

Operates as a bioscience company engages in developing healthy aging products.

NAGE

US$10.50

7D

13.6%

1Y

201.7%

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

CRON

CA$2.92

7D

5.0%

1Y

-29.5%

CorMedix

Market Cap: US$788.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$11.69

7D

-2.8%

1Y

124.8%

Ardelyx

Market Cap: US$784.8m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$3.38

7D

-7.1%

1Y

-56.6%

Zymeworks

Market Cap: US$783.9m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

ZYME

US$11.53

7D

1.9%

1Y

22.9%

LENZ Therapeutics

Market Cap: US$777.7m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

LENZ

US$27.34

7D

5.7%

1Y

65.4%

CureVac

Market Cap: US$758.8m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CVAC

US$3.43

7D

-4.6%

1Y

-1.6%

Geron

Market Cap: US$757.9m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

GERN

US$1.21

7D

-4.0%

1Y

-69.0%

Praxis Precision Medicines

Market Cap: US$755.7m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

PRAX

US$37.20

7D

-2.3%

1Y

-17.7%

Bicara Therapeutics

Market Cap: US$747.1m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

BCAX

US$14.47

7D

10.2%

1Y

n/a

WELL Health Technologies

Market Cap: CA$1.0b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

WELL

CA$4.12

7D

5.9%

1Y

6.7%

Xeris Biopharma Holdings

Market Cap: US$743.1m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

XERS

US$4.79

7D

-7.2%

1Y

137.1%

Nuvation Bio

Market Cap: US$738.4m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

NUVB

US$2.24

7D

6.7%

1Y

-34.3%

Nurix Therapeutics

Market Cap: US$730.3m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

NRIX

US$9.46

7D

-1.9%

1Y

-38.6%

Veradigm

Market Cap: US$712.6m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

MDRX

US$4.45

7D

-0.9%

1Y

-43.3%

Anavex Life Sciences

Market Cap: US$697.5m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

AVXL

US$8.37

7D

-2.2%

1Y

86.0%

Immunome

Market Cap: US$693.5m

A clinical-stage biotechnology company, develops targeted cancer therapies.

IMNM

US$8.00

7D

3.8%

1Y

-44.4%

uniQure

Market Cap: US$692.3m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

QURE

US$13.25

7D

8.2%

1Y

161.3%

Embecta

Market Cap: US$677.3m

A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

EMBC

US$11.66

7D

-12.3%

1Y

-17.9%

Nika Pharmaceuticals

Market Cap: US$672.8m

Engages in the development and distribution of various pharmaceutical products.

NIKA

US$0.66

7D

n/a

1Y

-6.1%

Curaleaf Holdings

Market Cap: CA$931.6m

Produces and distributes cannabis products in the United States and internationally.

CURA

CA$1.24

7D

2.5%

1Y

-83.9%

Akebia Therapeutics

Market Cap: US$667.1m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

AKBA

US$2.54

7D

-0.4%

1Y

120.9%

IRADIMED

Market Cap: US$660.0m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

IRMD

US$53.86

7D

2.3%

1Y

26.3%

PolyNovo

Market Cap: AU$1.0b

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

PNV

AU$1.49

7D

1.7%

1Y

-32.5%

Mesa Laboratories

Market Cap: US$652.6m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

MLAB

US$121.35

7D

-3.3%

1Y

0.6%

Page 10 of 65